P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000849300.97009.0e |
| _version_ | 1797285893994708992 |
|---|---|
| author | M. Dimou M. Speletas C. Milito D. Huscher M. Kamieniak D. Pittrow M. Borte |
| author_facet | M. Dimou M. Speletas C. Milito D. Huscher M. Kamieniak D. Pittrow M. Borte |
| author_sort | M. Dimou |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:10:01Z |
| format | Article |
| id | doaj.art-cdb4ea6db83449598285127ff67698d6 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:10:01Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-cdb4ea6db83449598285127ff67698d62024-03-02T07:47:25ZengWileyHemaSphere2572-92412022-06-0161492149310.1097/01.HS9.0000849300.97009.0e202206003-01492P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDYM. Dimou0M. Speletas1C. Milito2D. Huscher3M. Kamieniak4D. Pittrow5M. Borte61 First Department of Propaedeutic Internal Medicine, National & Kapodistrian University of Athens Medical School, General Hospital “LAIKO”, Athens2 School of Health Sciences Faculty of Medicine, Department of Immunology and Histocompatibility, Medical School Campus - University of Thessaly, Thessaly, Greece3 Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy4 Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Berlin, Germany5 Global Medical, Takeda Pharma Sp.z.o.o., Warsaw, Poland6 Institute for Clinical Pharmacology, Medical Faculty, Technical University of Dresden, Dresden7 Hospital for Children and Adolescents, St. Georg Hospitalhttp://journals.lww.com/10.1097/01.HS9.0000849300.97009.0e |
| spellingShingle | M. Dimou M. Speletas C. Milito D. Huscher M. Kamieniak D. Pittrow M. Borte P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY HemaSphere |
| title | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
| title_full | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
| title_fullStr | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
| title_full_unstemmed | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
| title_short | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
| title_sort | p1611 insights into facilitated immunoglobulin fscig use in patients with secondary immunodeficiency diseases final results from the figaro study |
| url | http://journals.lww.com/10.1097/01.HS9.0000849300.97009.0e |
| work_keys_str_mv | AT mdimou p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT mspeletas p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT cmilito p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT dhuscher p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT mkamieniak p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT dpittrow p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT mborte p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy |